T1	Participants 108 147	patients with advanced cervical cancer.
T2	Participants 307 335	advanced cervical carcinoma.
T3	Participants 354 511	Between May 2000 and May 2004, 31 women with FIGO stage IB2-IVA cervical cancer or with postsurgical pelvic recurrence were enrolled into this phase II study
T4	Participants 834 875	RESULTS Patient and tumor characteristics
T5	Participants 1515 1551	for advanced carcinoma of the cervix
